Superiority of ceftazidime off-label high-dose regimen in PK/PD target attainment during treatment of extensively drug-resistant Pseudomonas aeruginosa infections in cancer patients.
Br J Clin Pharmacol
; 89(4): 1452-1461, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36422512
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pseudomonas Infections
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Br J Clin Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: